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Bruising and bleeding are commonly seen in children and are usually associated with minor injury and trauma [1-3]. However, in two subsets of children, bleeding may be more 
significant than expected: Those having underlying hemostatic 
abnormalities such as an inherited bleeding disorder or those 
who have been subjected to non-accidental injury (NAI) [4-6]. 
The presentation of an infant or child with symptoms of bruising 
and/or bleeding commonly causes considerable anxiety to both 
pediatricians and hematologists. These symptoms may be due to a 
hemostatic disorder or due to NAI or both and making an accurate 
assessment and diagnosis is vital to ensure that the further 
management of that child is appropriate and the correct treatment 
is given if necessary [7-11]. Various studies in the past have tried 
to pick any one component of coagulation pathway or in isolation 
a single bleeding problem and tried to study it in detail [12-17]. 
However, this attempt by authors has been an effort to bring out 
the profile of children presenting in the Department of Pediatrics 
with bleeding manifestations.
MATERIALS AND METHODS
This prospective study was carried out on consecutive patients 
from newborn to children up to 14 years of age admitted to the 
Department of Pediatric from December 2013 to November 2014 
at Pandit B D Sharma Postgraduate Institute of Medical Sciences, 
Rohtak, Haryana. Children presenting with non-traumatic 
spontaneous bleeding or significant bleeding following trivial 
trauma were studied. Newborns requiring neonatal intensive 
care and children who developed bleeding during hospital stay 
were excluded from this study. Patients were divided into four 
age groups (Group A to D) ranging 0-1 month, >1 month-1 year, 
>1 year-7 year, and >7-14 years. Ethical clearance was taken from 
the Institutional Ethical Committee. Both the written and verbal 
consents were obtained from the parents. Their detailed history 
and physical examination were recorded.
The following investigations were done in all patients on the 
day of admission and repeated as and when required: Complete 
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hemogram with absolute platelet count, standard bleeding 
time (BT), prothrombin time (PT), partial thromboplastin 
time (PTT), and clotting time (CT). Bone marrow examination 
was done in cases who presented with either pancytopenia or 
hemogram with peripheral smear showing atypical cells or 
patients in whom immune thrombocytopenic purpura (ITP) was 
suspected. Fibrin degradation product (FDP) levels were assessed 
in patients in whom disseminated intravascular coagulation (DIC) 
was suspected. All these hematological investigations were 
performed by the standard techniques (Dacie and Lewis) [18].
Leukocytosis was defined as total leukocyte count (TLC) 
>11000/mm3 and leukopenia as TLC <4000/mm3. The WHO 
criteria for anemia were used to define anemia, that is, neonates 
(hematocrit <45%), children 6-59 months age (hemoglobin [Hb] 
<11 g/dl), children 5-11 years (Hb <11.5 g/dl), and children 
12-14 years (Hb <12 g/dl). The detailed history was recorded and 
cases were investigated as per the standard neonatal and pediatric 
guidelines. Transfusion of the blood products was done according 
to the standard pediatric transfusion guidelines. Statistical 
methods such as frequencies, descriptive were used to analyze 
the data, employing the SPSS 11.0 package.
RESULTS
A total of 92 children, admitted in pediatric ward, fulfilled the 
inclusion criteria and taken up for this study. The age and sex 
distribution of cases in different pediatric age groups are shown in 
Table 1. More number of male children presented with bleeding 
in <7 years age; however, after 7 years, no sex predominance 
was seen. Out of 92 patients, 78 children (84.8%) presented with 
bleeding symptoms (Table 2). Among the bleeding symptoms, the 
most common were hematemesis in 22 cases (23.91%), melena 
in 21 cases (22.8%) followed by epistaxis in 15 cases (16.3%). 
The age-wise distribution of the bleeding symptoms is depicted 
in Table 2. On examination, about 73 children (79.34%) had 
bleeding signs in the form of skin, subcutaneous, and joint bleed 
(Table 2). Maximum cases had purpura and ecchymotic spots 
(28 cases, 30.4% each), followed by petechial bleeds (12 cases, 
13%) and hemarthrosis in 5 cases (5.4%).
Anemia was present in 90 cases (97.8%). Out of these, 13 cases 
(l4.1%) had severe anemia. Leukocytosis was present in 13 cases 
(14.1%), whereas leukopenia was present in 10 cases (10.9%). 
34 children (36.96%) had neutrophilia, whereas 5 (5.4%) children 
had lymphocytosis. 42 cases (45.67%) had thrombocytopenia 
(platelets <50,000/mm3) while one case had thrombocytosis 
(platelets >450,000/mm3). Almost half of the children with 
bleeding manifestations in each age group had thrombocytopenia. 
Of all thrombocytopenic children, 5 cases (11.9%) had platelet 
count <25,000/mm3, whereas 22 children (52.4%) had platelet 
counts between 25,000/mm3 and 55,000/mm3. Out of a total 
of 42 cases of thrombocytopenia, 4 cases (9.5%) expired due 
to massive bleeding. 38 cases (90.5%) of thrombocytopenia 
recovered.
The platelet count returned to normal earliest in Group D 
(5.2 days) while in group B, it took longest for the platelet count 
to normalize (12.6 days) and the average number of days (of the 
total cases) when the platelet count became normal was 8.48 days. 
PT was deranged in 26 children (28.3%). PTT was deranged in 
33 children (35.9%). BT was prolonged in 2 children (2.2%) and 
CT was prolonged in 5 children (5.4%). FDP levels were elevated 
in 4 children (4.3%). Bone marrow examination was done in 
16 cases. Out of these, 6 had hypoplastic, 6 had megakaryocytic 
thrombocytopenia, and 4 had leukemia.
The age-wise distribution of the final diagnosis of the patients 
is shown in Table 3. We were able to made diagnosis in 82 children 
(89.1%). Among 82 patients, 31 (37.8%) had bleeding secondary 
to infections, 11 (13.4%) had coagulation disorder, 9 (10.97%) 
had Henoch–Schonlein purpura (HSP) and ITP each, 6 (7.3%) 
had hypoplastic bone marrow, 2 (2.4%) had chronic malaria, 
4 (4.9%) had leukemia, 6 (7.3%) had liver diseases, and 6 (7.3%) 
had hemorrhagic disease of newborn (HDN). Among patients 
with HDN, 3 had classical and 3 had late-onset disease. Among 
the coagulation disorders, nine cases (81.8%) had hemophilia A 
and two cases had hemophilia B. Out of these, 5 manifested with 
hemarthrosis (45.45%). Family history was positive in 7 cases 
(77.8%) of hemophilia A. The most common manifestations 
in patients with hemophilia were epistaxis, gingival bleed, 
hemarthrosis, and ecchymotic spots. The most common clinical 
manifestations in patients with ITP were bruises in 6 cases 
(66.6%), epistaxis in 3 (33.3%), and petechial rash in 5 cases 
(55.6%). The most common clinical presentation in HSP patients 
was purpuric rash (8 cases, 88.8%), arthralgia (5 cases, 55.6%), 
and abdominal pain (3 cases, 33.3%).
Maximum incidence of thrombocytopenia was due to infective 
causes (17 cases, 40.47%) followed by ITP (9 cases, 21.43%), 
hypoplastic anemias (6 cases, 14.28%), leukemias (4 cases, 
9.52%), and other causes (14.3%). The maximum incidence of 
bleeding in 0-1 month age group was due to infective causes, that 
is, 10 cases (58.8%), out of which, maximum cases were associated 
with thrombocytopenias and rest of the neonates (17.6%) had 
HDN. The predominant cause of bleeding in >1 month-1 year 
of age group was sepsis. Of the total 22 cases, 9 cases were of 
infective origin (40.9%), followed by HDN and coagulation 
disorders (3 cases each) and one case (4.5%) of hypoplastic 
anemia. In the age group of >1-7 years, the most common cause 
of bleeding was coagulation disorders in 6 cases (24%) followed 
by 5 cases of ITP (20%), 5 cases of infection (20%), 3 cases of 
hypoplastic anemia (12%), 2 cases each of HSP, acute leukemia, 
and liver disease (8% each). In children >7-14 years, maximum 
number presented with HSP in 7 cases (25%) and infections in 
Table 1: Age and sex distribution of the cases
Group Age Male 
n=65 (%)
Female 
n=27 (%)
Total 
n=92 (%)
A 0-1 month 13 (20) 4 (14.8) 17 (18.5)
B >1 month-1 year 18 (27.7) 4 (14.8) 22 (23.9)
C >1-7 years 21 (32.3) 4 (14.8) 25 (27.2)
D >7-14 years 13 (20) 15 (55.6) 28 (30.4)
Vol 4 | Issue 3 | Jul - Sep 2017 Indian J Child Health 338
Bhalla et al. Bleeding disorders in children
7 cases (25%) followed by liver disease and ITP in 4 cases each 
and 2 (7.1%) cases each of hypoplastic anemia and leukemia.
DISCUSSION
Bleeding complications in children may be caused by disorders of 
secondary hemostasis or fibrinolysis [1-3]. A child who presents 
with bleeding warrants evaluation for a significant bleeding 
problem. The child’s age, gender, and family history provide 
important clues in decision-making. Exaggerated bleeding 
responses to the commonly encountered events are suggestive 
of an underlying bleeding disorder. There is a paucity of the 
literature regarding the incidence of various causes of bleeding. 
Studies have mainly directed to a subgroup such as coagulation 
disorder, immune thrombocytopenia, and HSP [13-17,19]. We did 
not come across any study which covers all the causes of bleeding 
in children and its presentation in different age groups. Hence, 
this study was planned to give an overview of various causes of 
bleeding in children and its manifestation in different age groups.
In our study, 92 children presented with bleeding at the time 
of admission out of which, 73 patients presented with skin, 
subcutaneous, and joint bleeds. In a study by Naseem et al. among 
571 children with pancytopenia or bicytopenia, bleeding was the 
presenting symptom in 26.6% patient with pancytopenia and 
12.1% patients with bicytopenia [20].
Among 9 cases of ITP, 4 presented between 1 and 7 years of 
age and 5 cases presented after 7 years of age. The most common 
clinical manifestations were bruises in 6 cases (66.6%), epistaxis 
in 3 (33.3%), and petechial rashes in 5 cases (55.5%). Similarly, 
in a study by Alam, records of 95 children between 0 and 15 years 
suffering from ITP over 10 years period were reviewed. This 
study found that the mean age at the time of presentation was 
6.1±3.8 years and bruises 81 (85.3%), petechial rash 75 (79%), and 
epistaxis 23 (24%) were the common clinical presentations [19].
Table 3: Frequency distribution of etiology of bleeding in different age groups
Diagnosis Group A (n=17) Group B (n=22) Group C (n=25) Group D (n=28) Total (n=92)
HSP 0 0 2 (8) 7 (25) 9 (9.8)
Hypoplastic anemia 0 1 (4.5) 3 (12) 2 (7.1) 6 (6.5)
Infections
Sepsis with thrombocytopenia 7 (41.2) 5 (22.7) 1 (4) 0 31 (33.7)
Sepsis with DIC 3 (17.6) 3 (13.6) 0 1 (3.6)
Renal TB 0 0 1 (4) 1 (3.6)
Viral hemorrhagic fever 0 0 1 (4) 0
HUS 0 1 (4.5) 1 (4) 5 (17.9)
Chronic malaria 0 0 1 (4) 0
Liver disease 0 0 2 (8) 4 (14.3) 6 (6.5)
ITP 0 0 5 (20) 4 (14.3) 9 (9.8)
Acute leukemia 0 0 2 (8) 2 (7.1) 4 (4.3)
HDN 3 (17.6) 3 (13.6) 0 0 6 (6.5)
Coagulation disorders 0 3 (13.6) 6 (24) 2 (7.1) 11 (12)
HSP: Henoch–Schonlein purpura, DIC: Disseminated intravascular coagulation, TB: Tuberculosis, HSU: Hemolytic-uremic syndrome, ITP: Immune thrombocytopenic purpura, 
HDN: Hemorrhagic disease of newborn
Table 2: Frequency relationship of bleeding symptoms and signs at admission in different age groups
Clinical features Group A (n=17) Group B (n=22) Group C (n=25) Group D (n=28) Total (n=92)
Bleeding symptoms at admission
Epistaxis 0 2 (9.1) 9 (36) 4 (14.3) 15 (16.3)
Gingival bleeding 0 1 (4.5) 3 (12) 3 (10.7) 7 (7.6)
Hematemesis 6 (35.3) 6 (27.3) 6 (24) 4 (14.3) 22 (23.9)
Melena 8 (47.1) 7 (31.8) 4 (16) 2 (7.1) 21 (22.8)
Hemoptysis 0 0 0 1 (3.6) 1 (1.1)
Hematuria 1 (5.9) 0 1 (4) 4 (14.3) 6 (6.5)
Intracranial bleed 1 (5.9) 4 (18.2) 1 (4) 0 6 (6.5)
Total 16 (94.1) 20 (90.9) 24 (96) 18 (64.3) 78 (84.8)
Bleeding signs on examination
Petechia 1 (5.9) 1 (4.5) 4 (16) 6 (21.4) 12 (13)
Purpura 3 (17.6) 3 (13.6) 10 (40) 12 (42.9) 28 (30.4)
Ecchymosis 4 (23.5) 10 (45.5) 7 (28) 7 (25) 28 (30.4)
Hemarthrosis 0 0 3 (12) 2 (7.1) 5 (5.4)
Total 8 (47.1) 14 (63.6) 24 (96) 27 (96.4) 73 (79.3)
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Among the coagulation disorders, hemophilia A (81.8%) was 
the most common coagulation disorder followed by two cases 
of hemophilia B. The family history was positive in 7 cases 
(77.78%) of hemophilia A. The incidence of the disease may 
be high because of our institution is the premier referral center 
in Haryana. The most common manifestations were epistaxis, 
gingival bleed, hemarthrosis, and ecchymotic spots. Similarly, in 
a study by Lakshmi et al. in Andhra Pradesh, 66 diagnosed cases 
of hemophilia <15 years of age were analyzed. Hemophilia A was 
seen in 51 (77%) cases and 15 (23%) cases were identified as 
hemophilia B. Only 49% cases had a family history of bleeding. 
Hemarthrosis (68%) was the most common problem with which 
the patients presented. Gum bleeding was the second most 
common presentation followed by prolonged bleeding after tooth 
extraction, bruises, and ecchymosis [17].
In our study, among nine cases of HSP, 77.8% of cases presented 
after 7 years of age. The most common clinical presentation was 
purpuric rash (8 cases, 88.8%), arthralgia (5 cases, 55.6%), and 
abdominal pain (3 cases, 33.3%). This is comparable to a study 
by Lewis, which also showed that this condition is uncommon 
in children younger than 2 years of age [21]. In a study by 
Bagga et al., 47 patients were diagnosed to have HSP and the 
mean age of presentation was 8.5±2.8 years (3-12 years). The 
presenting manifestations were skin rash (29 cases, 62%), joint 
pain (10 cases, 21%), and abdominal pain (8 cases, 17%) [15]. In 
a study by Shahzad et al. in Kashmir, 27 patients (17 males and 
10 females) were diagnosed to have HSP. The common clinical 
features were purpuric rash in 17 (100%), abdominal pain in 
18 (66.6%), and arthritis/arthralgias in 16 (59.26%) cases [22].
Vitamin K deficiency is one of the common causes of bleeding 
in neonatal period [23]. In our study, we found 6 cases of HDN 
and among them, 3 had classical and 3 had late-onset disease. In a 
retrospective study by Choo et al., 42 neonates diagnosed to have 
HDN, and the classical HDN was the most common presentation 
(48%), followed by early-onset (29%) and late-onset (24%) 
disease [24].
In our study, the maximum incidence of bleeding in 
0-1 month age group was due to infective causes in 10 cases 
(58.8%), out of which, maximum cases were associated with 
thrombocytopenia and rest of neonates (17.6%) had HDN. It has 
been known that the overall prevalence of thrombocytopenia in 
neonates ranges from 1% to 5% and is reported to be much 
higher in neonates admitted to NICUs, ranging from 22% to 
35% [16,25]. In our study, 47.05% of the neonates had infections 
thrombocytopenia. Gram-negative bacterial infections were the 
cause in most of our cases. Out of I7 neonates with bleeding, 
7 had septicemia with thrombocytopenia (41.2%) and 2 had 
thrombocytopenia associated with severe birth asphyxia. This 
is similar to findings by Oren et al. where they found sepsis as 
a major factor (43.0%) in neonatal thrombocytopenia [26]. In a 
prospective study in 200 neonates with thrombocytopenia, the 
most common neonatal risk factors were sepsis in 48.5% of 
babies and birth asphyxia in 20% of babies [27]. Hypoxia is 
common insult in the newborn period and it has been shown that 
hypoxia can induce neonatal thrombocytopenia [28,29]. Out 
of three asphyxiated at birth, two had thrombocytopenia and 
both of them expired. In our study, neonatal thrombocytopenia 
occurred by day 2 and resolved by day 8. These findings 
are similar to study by Oren et al. where they found that the 
thrombocytopenia occurred by day 2 in 43% of neonates and 
resolved by the day 8 in 61% [26]. Thus, in concordance with 
other studies, our study thus demonstrated that sepsis, hypoxia, 
and DIC play an important role in the etiology of neonatal 
thrombocytopenia [16,30,31].
Our study has few limitations such as we did not evaluate the 
patients for Von Willebrand disease, platelet function disorders, 
and rare coagulation disorders, doing this may have altered the 
results and also this being a single-center study; we should be 
cautious while extrapolating the results to a large population.
CONCLUSION
Our study found that the gastrointestinal tract is the most common 
site of bleeding in children presenting with non-traumatic 
spontaneous bleed, and thrombocytopenia was present in 50% 
of cases in each age group. We also found that infections are 
the most common cause of bleeding in younger children while 
immunological causes and coagulation disorders predominate in 
older children. Hence, while evaluating any child with bleeding, 
age at presentation is also an important parameter to find the 
etiological diagnosis.
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